VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Clonal hematopoiesis and implications in multiple myeloma

Adam Sperling, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, shares some insights into the role of clonal hematopoiesis (CH) in the development of various hematological malignancies, and further highlights the prognostic impact of CH in patients with multiple myeloma and the importance of investigating this further. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter